+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

How old is factor V Leiden mutation?

How old is factor V Leiden mutation?

Thrombosis and Haemostasis 86(6): 1591-1592

(PDF emailed within 1 workday: $29.90)

Accession: 046280524

Download citation: RISBibTeXText

PMID: 11776338

Related references

The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey. Clinical and Applied Thrombosis/Hemostasis 13(2): 166-171, 2007

Factor V Leiden mutation and factor II Leiden mutation in a healthy subject without thrombosis antecedent. American Journal of Human Genetics 67(4 Supplement 2): 380, October, 2000

Factor V Leiden Only a European problem? Extremely high prevalence of factor V Leiden mutation amongst Syrian blood donors. Annals of Hematology 76(SUPPL 1): A75, 1998

The Factor V (Leiden) Test: Evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutation. Thrombosis Research 96(2): 125-133, 1999

Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice. Critical Care Medicine 34(8): 2201-2206, 2006

Homozygous factor V Leiden and double heterozygosity for factor V Leiden and prothrombin mutation. Journal of Thrombosis and Thrombolysis 36(3): 324-331, 2014

MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion. La Clinica Terapeutica 154(5): 299-303, 2004

Gender-specific association of the factor V Leiden mutation with fertility and fecundity in a historic cohort. The Leiden 85-Plus Study. Human Reproduction 21(4): 967-971, 2006

Consensus statement regarding indications for Leiden (FVL-factor V Leiden) mutation determination when recommending combined hormonal contraception or hormone replacement therapy. Vnitrni Lekarstvi 49(6): 502-502, 2003

Prothrombin G20210A mutation, and not factor V Leiden mutation, is a risk factor for cerebral venous thrombosis in Brazilian patients. Journal of Thrombosis and Haemostasis 2(7): 1211-1212, 2004

A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation. British Journal of Haematology 163(3): 414-417, 2013

Combination of congenital coagulation disorders: Factor II gene mutation G20210A, Factor V Leiden gene mutation G1691A and protein S deficiency. a family study. Haematologica 88(6): Ecr20-Ecr20, 2003

Coexistence of a novel homozygous nonsense mutation in exon 13 of the factor V gene with the homozygous Leiden mutation in two unrelated patients with severe factor V deficiency. British Journal of Haematology 114(4): 871-874, September, 2001